An October recovery column urges gradual return after a marathon. Understand its soreness warning, recovery estimates and limits for injury rehabilitation.
On October 11, 2026, The Times-Tribune published a recovery column by physical therapist Paul J. Mackarey urging a gradual return after a marathon. His central warning was that feeling little or no soreness does not establish that a runner's muscles have fully recovered.
The column appeared in connection with the 29th annual Steamtown Marathon. Mackarey specializes in orthopedic and sports physical therapy and is an associate professor of clinical medicine at Geisinger Commonwealth School of Medicine.
His focus was the gap between crossing the finish line and returning to the usual training calendar. He argued that recovery deserves attention even when discomfort has faded.
This was a recovery column rather than a new clinical guideline. The timely message is about how to interpret recovery, not a newly established rule for when every runner should resume training.
Before the October column, Runner's World had described a staged return to running in a September 22, 2026, article. That report featured a four-week reverse-taper suggestion from exercise physiologist and running coach Christine Rockey.
Rockey suggested taking a few days off running. She then proposed keeping mileage to no more than 30% of usual mileage in the second post-race week and 60% in the third. Her suggested plan reached 100% in the fourth week.
In that article, a reverse taper means rebuilding mileage in stages after the race. It offers a way of describing the return without treating the finish line as a signal to resume the previous schedule immediately. The article also says the number of runs in the second week should depend on soreness and fatigue.
The October column therefore did not introduce the idea of gradual mileage rebuilding. It added a particular warning about relying on soreness when judging recovery. The distinction matters because a plan organized around mileage answers a different question from a discussion of muscle recovery.
One describes how much running an expert suggests doing. The other asks whether feeling comfortable tells the whole recovery story. Reading the two reports together helps separate those questions without treating their different calendars as competing instructions.
Mackarey writes that creatine kinase can remain above usual levels for up to four days after a marathon. The column presents creatine kinase as a marker associated with cellular damage. It says this can occur even in runners who report little or no significant soreness.
That is the basis for his warning against equating comfort with complete recovery. The report's message is narrower than saying every comfortable runner has a particular degree of damage. It draws attention to a possible difference between what runners feel and what a damage-associated marker may show.
The column also says marathon-related damage may affect muscle strength, power and endurance. Mackarey estimates recovery at three to four weeks for elite runners and four to six weeks for average runners.
Those timeframes refer to different questions from the four-day marker claim. The creatine kinase statement concerns a reported laboratory signal. The longer estimates concern the broader muscle recovery Mackarey discusses. Combining them into one deadline would blur that distinction.
For activity after the race, the column recommends taking it easy for a few days and taking short walks. It later suggests longer walks and slow jogging after a few weeks. Mackarey names the elliptical, bicycle and swimming as lower-impact cross-training options.
The overall direction is a gradual return rather than an immediate return to usual training volume. The report also makes room for activities other than running. These are the columnist's marathon-recovery recommendations, presented as a general approach rather than a personal exercise plan.
The people discussed in these reports are marathon runners. Neither article reports testing a return-to-activity timetable in adults recovering from orthopedic surgery, an injury or a recurring musculoskeletal condition. That boundary matters for ReboundBody readers whose recovery began with a medical problem rather than a race.
A marathon runner's post-race return and an injured adult's rehabilitation may both involve questions about resuming usual activity. That shared topic does not make their recovery calendars interchangeable. The connection is a question to discuss, not a timeline to transfer.
For someone in midlife or later life, the useful theme is the distinction between improved comfort and the demands of the intended activity. The marathon reports provide a way to frame that discussion. They do not describe an age-specific rehabilitation population.
Readers navigating surgery can find related context in our coverage of the transition from rehabilitation to sport. The reason to connect these topics is to clarify the decision being considered, not to use a marathon column as evidence for a surgical recovery schedule.
The most useful response to these reports is to separate the questions that can become tangled in a recovery headline. Feeling better is one question. Returning to usual mileage is another. Recovering the strength and endurance discussed by Mackarey is a third.
For personal decisions after injury or surgery, those questions belong with a qualified healthcare professional who knows the reader's situation. The reports can help readers describe what they are trying to understand without requiring them to adopt either author's calendar.
A statement about “full recovery” is easier to interpret when its outcome is clear. In Mackarey's column, the discussion includes muscle strength, power and endurance. In Rockey's suggested schedule, the main number being rebuilt is running mileage.
Those are related topics but different measures. Useful discussion questions include:
Our discussion of what readiness assessments measure provides another way to think about naming the outcome. The aim is to make the question clearer before treating a number as an answer.
Rockey's percentages make her suggested progression easy to picture. They express how much usual running mileage returns at each stage of her approach. They should be read in that context rather than as percentages of complete physical recovery.
The broader editorial question is what “back to normal” means for the reader. It might refer to a previous running schedule or to an everyday activity after a setback. Naming that goal gives a healthcare conversation a more specific focus than simply asking whether recovery is finished.
Mackarey's references to walking and lower-impact cross-training show that his column does not frame recovery as an immediate choice between no activity and normal running. It describes a middle period in which activity is gradually reintroduced.
For someone already receiving care, the relevant question is how that broad idea fits the plan their clinician has established. The named activities are topics for discussion rather than a substitute for that plan. Related reading on planning the move back toward exercise keeps the focus on understanding the transition.
The largest uncertainty is the basis for Mackarey's recovery ranges. The column does not identify a supporting study for each estimate. It also does not define “elite” and “average” runners or explain how those categories were assigned.
The reporting does not account for individual differences in race effort or training history. It also leaves questions about health, age and injury status unanswered. Without that detail, the estimates cannot be matched precisely to an individual reader.
The creatine kinase statement has a separate limit. A reported damage-associated marker is not a personalized assessment of readiness to exercise. The column does not provide a clinical testing or clearance process built around that marker.
Rockey's reverse taper is an expert's suggested approach. The available reporting does not establish its percentages as a tested universal schedule or a sports-medicine consensus standard. That remains important even though the numerical progression is easy to remember.
More useful evidence would clearly define the runners being discussed and the outcomes being measured. It would also distinguish changes in symptoms from changes in muscle function and return to usual training. Those details would make recovery estimates easier to interpret without turning them into promises.
The October 11 column returns attention to the space between the finish line and the training calendar. Its strongest contribution is not a date to circle. It is a reason to understand what recovery means before treating the next scheduled run as proof that the process is complete.
Interpreting a marathon recovery estimate before resuming usual activity is an information decision that ReboundBody supports through evidence-aware recovery writing. For active adults uncertain about the shift from formal rehabilitation to everyday movement, the site explains mobility and strength rebuilding with realistic limits to support better-informed discussions with their healthcare team.
Follow ReboundBody for practical articles on injury recovery, rehabilitation, mobility and rebuilding strength. New posts turn research into clear ideas for the road back to activity after injury or surgery.
Read practical guidance on injury recovery, rehabilitation, mobility and rebuilding strength as you work your way back to activity.
Explore Resources